The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak

Creative Commons License

Zubarioglu T., Hopurcuoglu D., Uygur E., Ahmadzada S., Oge-Enver E., Isat E., ...Daha Fazla

TELEMEDICINE AND E-HEALTH, cilt.28, sa.2, ss.258-265, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1089/tmj.2020.0569
  • Dergi Adı: TELEMEDICINE AND E-HEALTH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, Compendex, EMBASE, MEDLINE, Psycinfo
  • Sayfa Sayıları: ss.258-265
  • Anahtar Kelimeler: PKU, telemedicine, monitoring, COVID-19, SARS-CoV-2, pandemic
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: The prognosis of phenylketonuria (PKU) in terms of neurocognitive outcome is directly related to lifelong phenylalanine (Phe) levels and adherence to treatment. Monitoring and treatment of PKU patients can be complicated in challenging circumstances as pandemics. This study aims to evaluate the impact of telemedicine for monitoring and treatment of PKU patients on metabolic outcome during coronavirus disease-19 (COVID-19) outbreak.